UNSPSC 51182427: Clodronate or clodronic acid

This classification denotes a bone resorption inhibitor and biphosphonate with the molecular formula CH4Cl2O6P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0813BZ6866, chemically known as 2-chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1h-isoindol-1-yl)benzenesulfonamide but generally known as clodronic acid, which bears US NIH Compound Identifier 2732. European Medicines Agency schedules Clodronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06693MIG.

UNSPSC 51182427 Clodronate or clodronic acid is a Commodity code covering a bisphosphonate medication used primarily to treat bone loss, hypercalcemia of malignancy, and related bone diseases. State and local governments procure this pharmaceutical through health departments, Medicaid programs, county hospitals, school district health clinics, and other public health and social service agencies that provide pharmacy services to eligible populations. The medication is typically sourced through group purchasing organizations (GPOs), state pharmaceutical contracts, or direct vendor agreements established by health procurement officers.

The source provided contains no recent state or local contract opportunities tagged to this code. Without posted solicitations or awarded contract records, no geographic concentration, representative recent RFPs or RFQs, or issuing-body activity pattern can be determined. Pharmaceutical commodities at the ingredient level often move through standing state and local health-services contracts and cooperative purchasing vehicles rather than through open competitive solicitations, which limits visibility into specific opportunities under this code.